RADA ‐16 Reduces Postoperative Epistaxis After Inferior Turbinate Submucosal Resection
The Laryngoscope · 2025
DOI: 10.1002/lary.32278 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2025. Verfasst von Annie Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA. Hauptthemen laut MEDLINE: Epistaxis, Turbinates, Postoperative Hemorrhage, Endoscopic Mucosal Resection. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objectives
RADA‐16 is a self‐assembling peptide matrix with the ability to form a hydrogel structure, showing promise for improved wound healing and hemostasis. Our objective was to understand the utility of RADA‐16 on postoperative bleeding rates following inferior turbinate submucosal resection (ITR) surgery. Study Design Retrospective study.
Methods
Electronic health records of patients who underwent ITR surgery with a single surgeon from January 2020 to March 2024 were reviewed. Univariate and multivariate analyses were performed to determine differences in postoperative epistaxis rates between RADA‐16 and non‐RADA‐16 cohorts. Further analysis was performed to compare healthcare‐associated costs.
Results
Our analysis included 985 patients who underwent ITR, of whom 571 received RADA‐16 and 414 did not. Overall, 1.11% of patients experienced postoperative bleeding, 0.35% in the RADA‐16 cohort and 2.17% in the non‐RADA‐16 cohort. Patients receiving RADA‐16 had a significantly lower risk of postoperative hemorrhage (OR 0.17, 95% CI 0.036–0.808, p = 0.026). Comparison of the two cohorts showed no significant difference in the prevalence of additional nasal surgery or bleeding disorders. The non‐RADA‐16 group was more likely to be on anticoagulation treatment ( p < 0.001); however, no relationship between anticoagulant usage and bleeding episodes was observed. After cost‐effectiveness analysis, we found the bleeding cost per patient was $379.74 for the RADA‐16 group and $436.21 for the non‐RADA‐16 group ( p = 0.36).
Conclusions
RADA‐16 is believed to improve wound healing and hemostasis. In our study, we found that patients receiving RADA‐16 are less likely to experience epistaxis following ITR surgery. Level of Evidence 3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
- Center for Skull Base and Pituitary Surgery, Neurological Institute of New Jersey, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
- Department of Neurological Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
- Department of Ophthalmology and Visual Science, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
- Department of Otolaryngology and Facial Plastic Surgery, Saint Barnabas Medical Center-RWJBarnabas Health, Livingston, New Jersey, USA.
ORCID-Profile: Annie Xu, Emily Kwon, Alexandra Filipkowski, Jean Anderson Eloy
Zitieren
APA
Xu, A., Kwon, E., Filipkowski, A., Feng, A. Y., Filimonov, A., Eloy, J. A., & Hsueh, W. D. (2025). RADA ‐16 Reduces Postoperative Epistaxis After Inferior Turbinate Submucosal Resection. The Laryngoscope. https://doi.org/10.1002/lary.32278
Vancouver
Xu A, Kwon E, Filipkowski A, Feng AY, Filimonov A, Eloy JA, et al. RADA ‐16 Reduces Postoperative Epistaxis After Inferior Turbinate Submucosal Resection. The Laryngoscope. 2025. doi:10.1002/lary.32278
BibTeX
@article{Xu2025,
author = {Xu, Annie and Kwon, Emily and Filipkowski, Alexandra and Feng, Anne Y and Filimonov, Andrey and Eloy, Jean Anderson and Hsueh, Wayne Daniel},
title = {RADA ‐16 Reduces Postoperative Epistaxis After Inferior Turbinate Submucosal Resection},
journal = {The Laryngoscope},
year = {2025},
doi = {10.1002/lary.32278}
}
EUVIMED